Posted by
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis

Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis

Summary Background Medicinal cannabinoids, including medicinal cannabis and pharmaceutical cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), have been suggested to have a therapeutic role in certain mental disorders. We analysed the available evidence to ascertain the effectiveness and safety of all types of medicinal cannabinoids in treating symptoms of various […]

Posted by
US health officials report new vaping deaths, repeat warning

US health officials report new vaping deaths, repeat warning

NEW YORK (AP) — U.S. health officials on Friday again urged people to stop vaping until they figure out why some are coming down with serious breathing illnesses. Officials have identified about 450 possible cases, including as many as five deaths, in 33 states. The count includes newly reported deaths in California, Indiana and Minnesota. […]

Posted by
Frequent Use of Medications for Sleep May Increase Dementia Risk, Especially Among Older White Adults

Frequent Use of Medications for Sleep May Increase Dementia Risk, Especially Among Older White Adults

Frequent use of sleep medications appears to be associated with increased long-term risk of dementia, particularly among older white adults, according to research presented at the Alzheimer’s Association International Conference in Los Angeles this week. “Based on our findings, we recommend that clinicians make more effort to be aware of their patients’ sleep problems including […]

Posted by
Estimates of Adult Benzodiazepine Use Double

Estimates of Adult Benzodiazepine Use Double

Baby boomers match seniors in the use of benzodiazepines, while misuse is most common in those aged 18 to 25. Over 30 million U.S. adults took benzodiazepines in the past year, including 5.3 million who misused the medication, according to a study posted December 17, 2018, in Psychiatric Services in Advance. The findings, which were based […]

Posted by
House Votes to Repeal Obamacare Tax Once Seen as Key to Health Law

House Votes to Repeal Obamacare Tax Once Seen as Key to Health Law

By Abby Goodnough WASHINGTON — In the heat of the legislative fight over the Affordable Care Act, Obama administration officials argued that including a steep tax on high-cost, generous health insurance plans was critical to the law because it would hold down soaring costs while helping to pay for its expanded health benefits. On Wednesday, that […]

Posted by
Intranasal esketamine combo tied to symptom improvement

Intranasal esketamine combo tied to symptom improvement

Concern raised about drug’s abuse potential Publish date: May 21, 2019 By Jim Kling REPORTING FROM APA 2019 SAN FRANCISCO – In treatment-resistant depression, a switch to a new antidepressant combined with inhaled esketamine (Spravato) led to better symptom improvement than did a switch to a new antidepressant plus placebo, results from a new trial show. The […]

Posted by
In scathing ruling, judge rips insurer for putting ‘bottom line’ over patients’ health

In scathing ruling, judge rips insurer for putting ‘bottom line’ over patients’ health

In a scathing decision, a federal judge blasted a subsidiary of the nation’s largest insurance company for focusing on the “bottom line as much or more” than patients’ health, saying the insurer illegally denied treatment to thousands of people. The judge also slammed the company’s medical directors for being “deceptive” under oath.US Chief Magistrate Judge […]

Posted by
FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic

FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic

For Immediate Release March 5, 2019 Release The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried other antidepressant medicines but have not benefited from them (treatment-resistant depression). Because of the risk of serious adverse outcomes resulting […]

Posted by
FDA Clears 3-Minute Brain Stimulation Protocol for Depression

FDA Clears 3-Minute Brain Stimulation Protocol for Depression

The US Food and Drug Administration (FDA) has approved a newer and faster treatment protocol for the MagVita repetitive transcranial magnetic stimulation (rTMS) therapy system from MagVenture, the company has announced. The FDA first cleared the MagVitaTMS therapy system in 2015 for treatment of adults with drug-resistant major depressive disorder, as reported by Medscape Medical News. Until now, each treatment […]